Veradermics Reports First Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress
Go back to Veradermics Reports First Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress| (NYSE: MANE) | Delayed: 102.79 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $102.79 | 52 Week High | $ | |||
| Open | $102.79 | 52 Week Low | $ | |||
| Day High | $102.79 | P/E | N/A | |||
| Day Low | $102.79 | EPS | $ | |||
| Volume | 26 | |||||

